Skip to content
2000
Volume 2, Issue 1
  • ISSN: 0250-6882
  • E-ISSN: 0250-6882
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Wilms Tumor (WT) is the most common pediatric kidney tumor, yet the disease has variable clinical characteristics and prognostic outcomes across different populations.

This study aims to review the clinical characteristics and survival outcomes of children with WT who have received treatment at Dubai Hospital, UAE.

A retrospective study was conducted involving the medical records of confirmed WT children (aged < 14 years) who had received treatment between 2013 and 2018. Diagnosis should have been established based on the histopathological examination of operable tumors and needle biopsy for inoperable tumors. The Société Internationale d’Oncologie Pédiatrique (SIOP) WT 2001 protocol was used for patient management, and the UMBRELLA SIOP–RTSG 2016 Wilms tumor pathology and molecular biology protocol was used for histopathologic classification and clinical staging. The presenting sign and symptoms, the findings of diagnostic imaging techniques, histological grading, the received treatments, and follow-up outcomes were collected and analyzed. Kaplan-Meier survival analysis was used to carry out the survival analysis.

Ten children were diagnosed with WT (median age of 3.40 years, 60% males). All patients presented with abdominal masses without prominent pain. Synchronous bilateral lesions were found at diagnosis in one patient and metastatic lesions in three patients. Four children were discharged against medical advice; five received treatment according to the SIOP WT 2001 regimen, while the remaining patient was managed in the United States according to the National Wilms Tumor Study Group (NWTSG) protocol. The overall 6-year and relapse-free survival rates were 90% and 80%, respectively.

The clinical characteristics and managemental outcomes of children presenting with WT are promising, possibly owing to adopting the SIOP protocol. Considering the small sample size, more large-scale, nation-wide studies are warranted.

© 2021 Bentham Science Publishers
© 2021 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0250688203666210111153116
2021-01-11
2025-09-10

  • From This Site

    /content/journals/nemj/10.2174/0250688203666210111153116
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/nemj/2/1/NEMJ-2-1-21.html?itemId=/content/journals/nemj/10.2174/0250688203666210111153116&mimeType=html&fmt=ahah

References

  1. WilmsM. Die Mischgeschwülste der Niere.Leipzig, GermanyVerlag von Arthur Georgi1899
     [Google Scholar]
  2. American Cancer Society - Cancer Statistics CenterCancer Facts & Statistics USA2018Available from: https://cancerstatisticscenter.cancer.org/#!/childhood-cancer
    [Google Scholar]
  3. SzychotE. AppsJ. Pritchard-JonesK. Wilms’ tumor: biology, diagnosis and treatment.Transl. Pediatr.201431122410.3978/j.issn.2224‑4336.2014.01.0926835318
     [Google Scholar]
  4. DavidoffA.M. Wilms tumor.Adv. Pediatr.201259124726710.1016/j.yapd.2012.04.00122789581
     [Google Scholar]
  5. DumbaM. JawadN. McHughK. Neuroblastoma and nephroblastoma: a radiological review.Cancer Imaging2015155510.1186/s40644‑015‑0040‑625889326
     [Google Scholar]
  6. RabehW. AkelS. EidT. MuwakkitS. AbboudM. El SolhH. SaabR. Wilms tumor: Successes and challenges in management outside of cooperative clinical trials.Hematol. Oncol. Stem Cell Ther.201691202510.1016/j.hemonc.2015.12.00626802622
     [Google Scholar]
  7. WildeJ.C.H. LamerisW. van HasseltE.H. MolyneuxE.M. HeijH.A. BorgsteinE.G. Challenges and outcome of Wilms’ tumour management in a resource-constrained setting.Afr. J. Paediatr. Surg.20107315916210.4103/0189‑6725.7041620859020
     [Google Scholar]
  8. DomeJ.S. GrafN. GellerJ.I. FernandezC.V. MullenE.A. SpreaficoF. Van den Heuvel-EibrinkM. Pritchard-JonesK. Advances in wilms tumor treatment and biology: Progress through international collaboration.J. Clin. Oncol.201533272999300710.1200/JCO.2015.62.188826304882
     [Google Scholar]
  9. NjugunaF. MartijnH.A. KuremuR.T. SaulaP. KirtikaP. OlbaraG. LangatS. MartinS. SkilesJ. VikT. KaspersG.J.L. MostertS. Wilms tumor treatment outcomes: perspectives from a low-income setting.J. Glob. Oncol.20163555556210.1200/JGO.2016.00538929094095
     [Google Scholar]
  10. HoneymanJ.N. RichB.S. McEvoyM.P. KnowlesM.A. HellerG. RiachyE. KobosR. ShuklaN. WoldenS.L. SteinherzP.G. La QuagliaM.P. Factors associated with relapse and survival in Wilms tumor: a multivariate analysis.J. Pediatr. Surg.20124761228123310.1016/j.jpedsurg.2012.03.03022703798
     [Google Scholar]
  11. United Nation Development Programme. Human Development Data (1990-2017)USA: The United Nation2018Available from: http://hdr.undp.org/en/data
  12. NawazA. MattaH. JacobszA. ShawisR. MpofuC. Al-SalemA. Wilms’ Tumor: The Tawam Hospital experience.Ann. Saudi Med.199919325726010.5144/0256‑4947.1999.25717283469
     [Google Scholar]
  13. NawazA. MpofuC. ShawisR. MattaH. JacobszA. KassirS. Al SalemA. Synchronous bilateral Wilms’ tumor.Pediatr. Surg. Int.1999151424510.1007/s0038300505099914354
     [Google Scholar]
  14. TournadeM.F. Com-NouguéC. de KrakerJ. LudwigR. ReyA. BurgersJ.M. SandstedtB. GodzinskiJ. CarliM. PotterR. ZuckerJ.M. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms’ tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms’ Tumor Trial and Study.J. Clin. Oncol.200119248850010.1200/JCO.2001.19.2.48811208843
     [Google Scholar]
  15. VujanićG.M. GesslerM. OomsA.H.A.G. ColliniP. Coulomb-l’HermineA. D’HoogheE. de KrijgerR.R. PerottiD. Pritchard-JonesK. VokuhlC. van den Heuvel-EibrinkM.M. GrafN. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.Nat. Rev. Urol.2018151169370110.1038/s41585‑018‑0100‑330310143
     [Google Scholar]
  16. PshakT.J. ChoD.S. HayesK.L. VemulakondaV.M. Correlation between CT-estimated tumor volume, pathologic tumor volume, and final pathologic specimen weight in children with Wilms’ tumor.J. Pediatr. Urol.201410114815410.1016/j.jpurol.2013.08.00124035637
     [Google Scholar]
  17. D’AngioG.J. EvansA. BreslowN. BeckwithB. BishopH. FarewellV. GoodwinW. LeapeL. PalmerN. SinksL. SutowW. TefftM. WolffJ. The treatment of Wilms’ tumor: results of the Second National Wilms’ Tumor Study.Cancer19814792302231110.1002/1097‑0142(19810501)47:9<2302::AID‑CNCR2820470933>3.0.CO;2‑K6164480
     [Google Scholar]
  18. ForthoferR.N. LeeE.S. HernandezM. Analysis of Survival Data. Biostatistics: A guide to design, analysis and discovery.2nd ed ForthoferR.N. LeeE.S. HernandezM. USAElsevier2006297315
     [Google Scholar]
  19. Statistics and Research CenterCancer Incidence in United Arab Emirates Annual Report of the UAE-National Cancer Registry UAE: Ministry of Health and Prevention2015Available from: https://www.mohap.gov.ae/Files/MOH_OpenData/1553/NATIONAL%20CANCER%20REGISTRY%20ANNUAL%20REPORT%20_%202015.pdf
    [Google Scholar]
  20. ChanC.C. ToK.F. YuenH.L. Shing ChiangA.K. LingS.C. LiC.H. CheukD.K. LiC.K. ShingM.M. A 20-year prospective study of Wilms tumor and other kidney tumors: A report from Hong Kong pediatric hematology and oncology study group.J. Pediatr. Hematol. Oncol.201436644545010.1097/MPH.000000000000001825050908
     [Google Scholar]
  21. PritchardJ. ImesonJ. BarnesJ. CotterillS. GoughD. MarsdenH.B. Morris-JonesP. PearsonD. Results of the United Kingdom Children’s Cancer Study Group first Wilms’ Tumor Study.J. Clin. Oncol.199513112413310.1200/JCO.1995.13.1.1247799012
     [Google Scholar]
  22. YildizI. YükselL. OzkanA. ApakH. CelkanT. DanismendN. BüyükünalC. SöyletY. SarimuratN. DervisogluS. AksoyF. AtkovarG. OkkanS. Multidisciplinary approach to Wilms’ tumor: 18 years of experience.Jpn. J. Clin. Oncol.2000301172010.1093/jjco/hyd00110770563
     [Google Scholar]
  23. NaguibS.F. El HaddadA. El BadawyS.A. ZaghloulA.S. Multidisciplinary approach to wilms’ tumor: a retrospective analytical study of 53 patients.J. Egypt. Natl. Canc. Inst.200820441042320571600
     [Google Scholar]
  24. YaoW. LiK. XiaoX. GaoJ. DongK. XiaoX. LvZ. Outcomes of Wilms’ tumor in eastern China: 10 years of experience at a single center.J. Invest. Surg.201225318118510.3109/08941939.2011.61589322583015
     [Google Scholar]
  25. MaherK. K H, S H. Wilms’ tumor in children: A single institution 10-year experience.Egypt. J. Hosp. Med.20145515916410.12816/0004501
     [Google Scholar]
  26. Al MulhimI. Wilm’s Tumor in Children: A 10-year Experience from the Eastern Province of Saudi Arabia.Saudi J. Kidney Dis. Transpl.19978212312618417789
     [Google Scholar]
  27. PastoreG. ZnaorA. SpreaficoF. GrafN. Pritchard-JonesK. Steliarova-FoucherE. Malignant renal tumours incidence and survival in European children (1978-1997): Report from the Automated Childhood Cancer Information System project.Eur. J. Cancer200642132103211410.1016/j.ejca.2006.05.01016919774
     [Google Scholar]
  28. Fawkner-CorbettD.W. HowellL. PizerB.L. DominiciC. McDowellH.P. LostyP.D. Wilms’ tumor: Lessons and outcomes: A 25-year single center UK experience.Pediatr. Hematol. Oncol.201431540040810.3109/08880018.2014.91270924933082
     [Google Scholar]
  29. DoganisD. PanagopoulouP. TragiannidisA. GeorgakisM.K. MoschoviM. PolychronopoulouS. RigatouE. PapakonstantinouE. StiakakiE. DanaH. BoukaE. AntunesL. BastosJ. CozaD. DemetriouA. AgiusD. EserS. RyzhovA. SekerijaM. TrojanowskiM. ZagarT. ZborovskayaA. PerisicS.Z. StefanakiK. DessyprisN. PetridouE.T. Childhood nephroblastoma in Southern and Eastern Europe and the US: Incidence variations and temporal trends by human development index.Cancer Epidemiol.201854758110.1016/j.canep.2018.03.01229655086
     [Google Scholar]
  30. DoganisD. ZborovskayaA. TrojanowskiM. ZagarT. BoukaP. BakaM. MoschoviM. PolychronopoulouS. PapakonstantinouE. TragiannidisA. StiakakiE. DanaH. StefanakiK. StrantziaK. KochubinskyD. MarciniakP. AvcinS. AntoniadiK. DessyprisN. PetridouE.T. Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999-2017).Eur. J. Cancer2019115374610.1016/j.ejca.2019.04.00831082691
     [Google Scholar]
  31. SenS. KadambaP. Al-AbdulAalyM. MammenK.E. AhmedS. Results of Wilms’ tumour management in two tertiary-care hospitals in Asia.Pediatr. Surg. Int.1998131424410.1007/s0038300502409391203
     [Google Scholar]
  32. JohnR. KurianJ.J. SenS. GuptaM.K. JehangirS. MathewL.G. MathaiJ. Clinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south India.J. Pediatr. Urol.2018146547.e1547.e710.1016/j.jpurol.2018.05.02030017606
     [Google Scholar]
  33. de KrakerJ. DelemarreJ.F. LilienM.R. TournadeM.F. Misstaging in nephroblastoma. Causes and consequences. A report of the Sixth Nephroblastoma Trial and Study of the International Society of Paediatric Oncology.Eur. J. Pediatr. Surg.19999315315710.1055/s‑2008‑107223210427490
     [Google Scholar]
  34. PleskoI. KramárováE. StillerC.A. CoeberghJ.W. SantaquilaniM. EUROCARE Working Group Survival of children with Wilms’ tumour in Europe.Eur. J. Cancer200137673674310.1016/S0959‑8049(01)00048‑X11311648
     [Google Scholar]
  35. GattaG. CapocacciaR. ColemanM.P. RiesL.A. BerrinoF. Childhood cancer survival in Europe and the United States.Cancer20029581767177210.1002/cncr.1083312365026
     [Google Scholar]
  36. Pritchard-JonesK. GrafN. van TinterenH. CraftA. Evidence for a delay in diagnosis of Wilms’ tumour in the UK compared with Germany: implications for primary care for children.Arch. Dis. Child.2016101541742010.1136/archdischild‑2015‑30921226948824
     [Google Scholar]
/content/journals/nemj/10.2174/0250688203666210111153116
Loading
The Clinical Characteristics and Survival Profiles of Wilms Tumor in the United Arab Emirates: A Single-center Retrospective Analysis
NEW Emirates Medical J 2, 84 (2021); https://doi.org/10.2174/0250688203666210111153116
/content/journals/nemj/10.2174/0250688203666210111153116
/content/journals/nemj/10.2174/0250688203666210111153116
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Chemotherapy; Hereditary; Kidney neoplasms; Survival; United Arab Emirates; Wilms tumor

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test